Influence of Food Preferences on the Occurrence of Undernutrition in Treated Patients for Bronchopulmonary Carcinoma Non-small Cell Stage IV (ONCOGOU)

Centre Georges Francois Leclerc

Status

Enrolling

Conditions

Non-small Cell Bronchopulmonary Carcinoma at Stage IV and Benefiting From First-line Treatment According to Current French Recommendations

Treatments

Other: Test Leeds Food Preference Questionnaire (LFQP-France)

Study type

Interventional

Funder types

Other

Identifiers

NCT05496556

2021-A01952-39

Details and patient eligibility

About

The study will be offered to patients with non-small cell lung carcinoma diagnosed at stage IV and receiving first-line treatment.

The patient will benefit from a complete assessment at inclusion (clinical exam, imagery, biological exam, dietary consultation, test LFQP.

At the end of this 1st evaluation, patients in whom the diagnosis of undernutrition is made will benefit from dietary management with personalized advice that will take into account the symptoms of cancer, the possible side effects of treatments as well as the social environment.

Every two cures, i.e. every 4 to 6 weeks, these examens will be performed until the occurrence of an event (progression of the disease according to the RECIST criteria, death or change of therapeutic line). At the end of these assessments, patients will benefit from dietary management with a readjustment of personalized advice that will take into account the difficulties highlighted during the assessment.

Enrollment

190 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Diagnosis of stage IV non-small cell lung carcinoma with indication for first-line systemic treatment (chemotherapy, immunotherapy or specific treatment, in particular tyrosine kinase inhibitors) according to current French recommendations.
Age over 18 and under 70
Patient speaking and reading French fluently
Affiliation to a social security scheme
Patient able and willing to follow all study procedures in accordance with the protocol
Patient having understood, signed and dated the consent form

Exclusion criteria

Patient requiring hospitalization for more than 48 hours for the administration of the first course of treatment
Patient benefiting from antibiotic therapy for the treatment of an acute infection
Psychiatric, cognitive or neurological disorders making it impossible to assess food preferences and/or any impossibility to undergo medical monitoring for the trial for geographical, social or psychological reasons.
Daily alcohol consumption
Chest radiotherapy treatment
Pregnant woman, likely to be, or breastfeeding
Persons deprived of liberty or under guardianship